The post Panera Bread releases first-ever value menu with ‘Mix & Match’ deals appeared on BitcoinEthereumNews.com. A steak sandwich and French onion soup from PaneraThe post Panera Bread releases first-ever value menu with ‘Mix & Match’ deals appeared on BitcoinEthereumNews.com. A steak sandwich and French onion soup from Panera

Panera Bread releases first-ever value menu with ‘Mix & Match’ deals

A steak sandwich and French onion soup from Panera Bread Co. arranged in the Queens borough of New York, US, on Tuesday, Dec. 12, 2023. 

Bing Guan | Bloomberg | Getty Images

Panera Bread is entering the so-called value wars with its new “Mix & Match” deals in a bid to win back price-conscious diners.

The chain, known for its soups, salads and sandwiches, is in the early stages of a turnaround, with a focus on reinvesting in its business and reversing years of traffic declines. Once the top fast-casual brand in the U.S., Panera has fallen to No. 3, ceding the top spots to Chipotle Mexican Grill and Panda Express.

In 2024, Panera’s sales fell 5% to $6.1 billion, according to Technomic estimates.

A key part of Panera’s comeback strategy is focusing on value.

Across the restaurant industry, executives have reported weaker spending among consumers, who are trying to save money by trading down to fast food or dining out less frequently. Chains like McDonald’s and Taco Bell have leaned into value offerings to try to win back customers.

About 3 out of every 4 diners said that daily specials, discounts or value promotions matter when choosing where to dine or order takeout, according to the National Restaurant Association’s annual State of the Restaurant Industry report.

“[Consumers] are seeking value, and they’re also seeking quality,” Panera CEO Paul Carbone told CNBC. “That’s so, so important.”

Starting Wednesday, Panera customers can choose halved portions of sandwiches and salads, as well as cups of soup, from the “Mix & Match” menu. Each of the 10 items is priced at $4.99, and diners have to buy at least two items. Seasonal menu items will also rotate through the “Mix & Match” options.

Each order also comes with the choice of a baguette, chips or an apple.

Panera explored other value offerings, but the “Mix & Match” menu tested successfully, Carbone said.

“The guest has really, really reacted well to it,” he said, adding the menu is expected to drive incremental visits to the restaurant.

And while Panera is introducing the deal, its popular “You Pick Two” offering is sticking around.

Carbone said that customer research showed that diners view the option to buy two entrees from the menu as an opportunity for variety, rather than a chance to save money. Like “Mix & Match,” the offer allows customers to choose a half salad, half sandwich or cup of soup or mac and cheese. However, “You Pick Two” spans the menu, rather than being restricted to just 10 items.

Source: https://www.cnbc.com/2026/02/25/panera-bread-releases-first-ever-value-menu-with-mix-match-deals.html

Market Opportunity
Everscale Logo
Everscale Price(EVER)
$0.00329
$0.00329$0.00329
-13.42%
USD
Everscale (EVER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion
Share
AI Journal2026/02/25 21:36
How BlackRock and JPMorgan Are Quietly Building On Blockchain - Institutional DeFi Is Here

How BlackRock and JPMorgan Are Quietly Building On Blockchain - Institutional DeFi Is Here

read more
Share
Coinstats2025/09/18 19:43